Artículos de revistas
Increased 27-hydroxycholesterol Plasma Level In Men With Low High Density Lipoprotein-cholesterol May Circumvent Their Reduced Cell Cholesterol Efflux Rate
Registro en:
Clinica Chimica Acta. Elsevier, v. 433, n. , p. 169 - 173, 2014.
98981
10.1016/j.cca.2014.03.017
2-s2.0-84897387988
Autor
Nunes V.S.
Panzoldo N.B.
Leanca C.C.
Parra E.S.
Zago V.S.
da Silva E.J.
Cazita P.M.
Nakandakare E.R.
de Faria E.C.
Quintao E.C.R.
Institución
Resumen
Background: HDL is considered the most important mechanism for the excretion of intracellular cholesterol. The liver is the only organ capable to metabolize cholesterol into bile acid. The enzymatic conversion of cholesterol to bile acid is dependent on the cytochrome P450 microsomal system which is also responsible for the generation of oxysterols. The latter's plasma concentrations may reflect the metabolic processes of specific tissues where they are generated. The objective of this study was to investigate in healthy individuals who differ according to their HDL levels the concentration of oxysterols and relate it to the HDL-dependent cell cholesterol efflux rate. Methods: 24-Hydroxycholesterol, 25-hydroxycholesterol, 27-hydroxycholesterol were determined in plasma by GLC/mass spectrometry in 107 healthy subjects with low HDL (HDL-C. <. 1.03. mmol/l) and high HDL cholesterol (HDL-C. >. 1.55. mmol/l). HDL-dependent in vitro cell cholesterol efflux rate was measured in 29 cases. Results: No differences were found in plasma oxysterol concentrations between the Low HDL and High HDL groups. There was a significant negative correlation between HDL-C and 27-hydroxycholesterol. Plasma oxysterol concentrations were significantly lower in female than in male subjects. The Low HDL male group had higher 27-hydroxycholesterol than the High HDL male group. Cell cholesterol efflux rate was lower in Low HDL than in High HDL and related inversely with 27-hydroxycholesterol. Conclusion: As compared to High HDL, Low HDL men have increased 27-hydroxycholesterol plasma level that may circumvent their reduced cell cholesterol efflux rate. © 2014 Elsevier B.V. 433
169 173 Gordon, T., Castelli, W.P., Hjortland, M.C., Kannel, W.B., Dawber, T.R., High density lipoprotein as a protective factor against coronary heart disease. The Framingham study (1977) Am J Med, 62, pp. 707-714 Rothblat, G.H., Phillips, M.C., High-density lipoprotein heterogeneity and function in reverse cholesterol transport (2010) Curr Opin Lipidol, 21, pp. 229-238 Nunes, V.S., Leança, C.C., Panzoldo, N.B., HDL-C concentration is related to markers of absorption and of cholesterol synthesis: study in subjects with low vs. high HDL-C (2011) Clin Chim Acta, 412, pp. 176-180 Jakulj, L., Besseling, J., Stroes, E.S., Groen, A.K., Intestinal cholesterol secretion: future clinical implications (2013) Neth J Med, 71, pp. 459-465 Tietge, U.J., Groen, A.K., Role the TICE?: advancing the concept of transintestinal cholesterol excretion (2013) Arterioscler Thromb Vasc Biol, 33, pp. 1452-1453 Björkhem, I., Meaney, S., Diczfalusy, U., Oxysterols in human circulation: which role do they have? (2002) Curr Opin Lipidol, 13, pp. 247-253 Monte, M.J., Marin, J.J., Antelo, A., Vazquez-Tato, J., Bile acids: chemistry, physiology, and pathophysiology (2009) World J Gastroenterol, 15, pp. 804-816 Duane, W.C., Javitt, N.B., 27-Hydroxycholesterol: production rates in normal human subjects (1999) J Lipid Res, 40, pp. 1194-1199 Axelson, M., Sjovall, J., Potential bile acid precursorsin plasma - possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man (1990) J Steroid Biochem, 36, pp. 631-640 Beigneux, A., Hofmann, A.F., Young, S.G., Human CYP7A1 deficiency: progress and enigmas (2002) J Clin Invest, 110, pp. 29-31 Lorbek, G., Lewinska, M., Rozman, D., Cytochrome P450s in the synthesis of cholesterol and bile acids-from mouse models to human diseases (2012) FEBS J, 279, pp. 1516-1533 Pikuleva, I.A., Cholesterol-metabolizing cytochromes P450 (2006) Drug Metab Dispos, 34, pp. 513-520 Lund, E., Andersson, O., Zhang, J., Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans (1996) Arterioscler Thromb Vasc Biol, 16, pp. 208-212 Bretillon, L., Lütjohann, D., Ståhle, L., Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface (2000) J Lipid Res, 41, pp. 840-845 Dietschy, J.M., Turley, S.D., Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. (2004) J Lipid Res, 45, pp. 1375-1397 Leoni, V., Caccia, C., 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases (2013) Biochimie, 95, pp. 595-612 Leoni, V., Oxysterols as markers of neurological disease-a review (2009) Scand J Clin Lab Invest, 69, pp. 22-25 Lund, E.G., Kerr, T.A., Sakai, J., Li, W.P., Russell, D.W., CDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism (1998) J Biol Chem, 273, pp. 34316-34327 Russell, D.W., Oxysterol biosynthetic enzymes (2000) Biochim Biophys Acta, 529, pp. 126-135 Weingärtner, O., Laufs, U., Böhm, M., Lütjohann, D., An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol (2010) Atherosclerosis, 209, pp. 39-41 Karuna, R., Holleboom, A.G., Motazacker, M.M., Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism (2011) Atherosclerosis, 214, pp. 448-455 Burkard, I., von Eckardstein, A., Waeber, G., Vollenweider, P., Rentsch, K.M., Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers (2007) Atherosclerosis, 194, pp. 71-78 Babiker, A., Diczfalusy, U., Transport of side-chain oxidized oxysterols in the human circulation (1998) Biochim Biophys Acta, 1392, pp. 333-339 Dzeletovic, S., Breuer, O., Lund, E., Diczfalusy, U., Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry (1995) Anal Biochem, 225, pp. 73-80 Ketomäki, A., Gylling, H., Siimes, M.A., Vuorio, A., Miettinen, T.A., Squalene and noncholesterol sterols in serum and lipoproteins of children with and without familial hypercholesterolemia (2003) Pediatr Res, 539, pp. 648-653 Björkhem, I., Andersson, O., Diczfalusy, U., Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages (1994) Proc Natl Acad Sci U S A, 91, pp. 8592-8596 Janowski, B.A., Willy, P.J., Devi, T.R., Falck, J.R., Mangelsdorf, D.J., An oxysterolsignalling pathway mediated by the nuclear receptor LXR alpha (1996) Nature, 383, pp. 728-731 Peet, D.J., Turley, S.D., Ma, W., Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha (1998) Cell, 93, pp. 693-704 Hirayama, T., Mizokami, Y., Honda, A., Serum concentration of 27-hydroxycholesterol predicts the effects of high-cholesterol diet on plasma LDL cholesterol level (2009) Hepatol Res, 39, pp. 149-156 Umetani, M., Shaul, P.W., 27-Hydroxycholesterol: the first identified endogenous SERM (2011) Trends Endocrinol Metab, 22, pp. 130-135 Yamamoto, Y., Moore, R., Hess, H.A., Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity (2006) J Biol Chem, 281, pp. 16625-16631 Nunes, V.S., Leança, C.C., Panzoldo, N.B., Plasma 27-hydroxycholesterol/cholesterol ratio is increased in low high density lipoprotein-cholesterol healthy subjects (2013) Clin Biochem, 46, pp. 1619-1621 Kannenberg, F., Gorzelniak, K., Jager, K., Characterization of cholesterol homeostasis in telomerase-immortalized tangier disease fibroblasts reveals marked phenotype variability (2013) J Biol Chem, 288, pp. 36936-36947 Björkhem, I., Diczfalusy, U., Lütjohann, D., Removal of cholesterol from extrahepatic sources by oxidative mechanisms (1999) Curr Opin Lipidol, 10, pp. 161-165